glucuronic acid has been researched along with Parkinson Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, DW; Cho, HY; Hong, JM; Kang, KS; Lee, JW; Lee, SI; Paek, SH; Son, JH | 1 |
| Sambanis, A; Tiernan, AR | 1 |
| Emerich, DF; Sandrof, MA; Thanos, CG | 1 |
| Choonara, YE; du Toit, LC; Khan, RA; Pillay, V; Singh, N | 1 |
| Bodde, HE; Danhof, M; Gubbens-Stibbe, JM; Kruger, P; van der Geest, R; van Laar, T | 1 |
5 other study(ies) available for glucuronic acid and Parkinson Disease
| Article | Year |
|---|---|
Hybrid scaffold composed of hydrogel/3D-framework and its application as a dopamine delivery system.
Topics: Alginates; Animals; Cells, Cultured; Dopamine; Dopamine Agents; Drug Delivery Systems; Female; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Mice; Mice, Inbred C57BL; Parkinson Disease; Tissue Scaffolds | 2014 |
Bioluminescence tracking of alginate micro-encapsulated cell transplants.
Topics: Alginates; Animals; Cell Survival; Cell Transplantation; Cross-Linking Reagents; Diabetes Mellitus; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Insulin-Secreting Cells; Luminescence; Male; Mice; Mice, Inbred BALB C; Pancreas; Parkinson Disease; Time Factors; Transplantation, Heterologous | 2017 |
Primary Choroid Plexus Tissue for Use in Cellular Therapy.
Topics: Alginates; Animals; Capsules; Cell Culture Techniques; Cell Separation; Cell- and Tissue-Based Therapy; Cells, Cultured; Cells, Immobilized; Choroid Plexus; Corpus Striatum; Culture Media, Conditioned; Epithelial Cells; Glucuronic Acid; Hexuronic Acids; Humans; Neurons; Parkinson Disease; Rats; Swine | 2017 |
Mechanistic evaluation of alginate-HEC gelisphere compacts for controlled intrastriatal nicotine release in Parkinson's disease.
Topics: Alginates; Cellulose; Cross-Linking Reagents; Drug Delivery Systems; Elasticity; Gels; Glucuronic Acid; Hexuronic Acids; Humans; Neuroprotective Agents; Nicotine; Parkinson Disease; Phase Transition; Surface Properties; Time Factors; Water | 2009 |
Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease.
Topics: Acetic Acid; Antiparkinson Agents; Apomorphine; Chromatography, High Pressure Liquid; Circadian Rhythm; Glucuronates; Glucuronic Acid; Glucuronidase; Humans; Hydrolysis; Infusions, Intravenous; Linear Models; Male; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Sulfatases; Sulfates; Time Factors | 1997 |